🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jeffrey J. Ishizuka

Yale University

ORCID: 0000-0002-4271-7312
MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma”.

Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma

Blood(2020)10.1182/blood.2020006464
N/A
1.9DataRank · unranked
59 citations

Jason L. Weirather, Margaretha G.M. Roemer, Mikel Lipschitz, Alyssa Kelley, Pei-Hsuan Chen +26 more

A phase II/III trial of chemotherapy plus cetuximab versus chemotherapy plus bevacizumab versus atezolizumab plus bevacizumab following progression on immune checkpoint inhibition in recurrent/metastatic head and neck cancers: ECOG-ACRIN EA3202.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps6098
N/A
0DataRank · unranked
5 citations

Yael Flamand, Jennifer M. Johnson, Jeffrey J. Ishizuka, Fenghai Duan, Mei Tang +4 more

Causal identification of single-cell experimental perturbation effects with CINEMA-OT

Nature Methods(2023)10.1038/s41592-023-02040-5
N/A
0DataRank · unranked
81 citations

Bao Wang, Jessica Wei, Antonio H. de O. Fonseca, Curtis J. Perry, Alexander Frey +6 more

Subsets of IFN Signaling Predict Response to Immune Checkpoint Blockade in Patients with Melanoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0215
N/A
0DataRank · unranked
10 citations

Daniel Y. Lee, Min Ding, Sandra Martínez-Morilla, Thazin Nwe Aung, Feriel Ouerghi +8 more

Subsets of interferon signaling and response to immune checkpoint blockade.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.9522
N/A
0DataRank · unranked
0 citations

Brooke Horowitch, Min Ding, Sandra Martínez-Morilla, Thazin Nwe Aung, Feriel Ouerghi +8 more

Real-world outcomes with T-VEC in patients with anti-PD-1 resistant in-transit disease from melanoma and Merkel cell carcinoma

Surgical Oncology Insight(2024)10.1016/j.soi.2024.100120
N/A
0DataRank · unranked
1 citations

Madeline McNamara, Margaret A. Kaszycki, Alexander E. Frey, Jeffrey J. Ishizuka, Philippos Apolinário Costa +6 more

Myeloid cells mediate interferon-driven resistance to immunotherapy in advanced renal cell carcinoma

Immunity(2025)10.1016/j.immuni.2025.10.013
N/A
0DataRank · unranked
8 citations

Soki Kashima, Sabrina Y. Camp, Kevin Meli, Eddy Saad, Breanna Titchen +14 more

Targeting an essential viral oncoprotein with an IL-7-enhanced mRNA vaccine induces durable immunity to Merkel cell carcinoma

Cell Reports(2025)10.1016/j.celrep.2025.116359
N/A
0DataRank · unranked
1 citations

Kathryn Clulo, Yuewei Fei, Therese Cordero Dumit, Frankie Scallo, Jerry William Allen +12 more

Perturbational single-cell RNA sequencing of patient tumors in Merkel cell and small cell lung carcinomas.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.2520
N/A
0DataRank · unranked
0 citations

Alexander Frey, Yuewei Fei, Philippos Apolinário Costa, Jason Z Wang, Sina Ghadermarzi +11 more